Bausch Health Companies (TSE:BHC) Stock Price Down 7.2% - What's Next?

Key Points

• Bausch Health Companies' stock price fell by 7.2%, trading as low as C$7.64 and closing at C$8.21, with trading volume down by 18% from average levels.
• Director John Paulson purchased 1,782,030 shares at C$8.14 each, contributing to a total insider acquisition of 3.55 million shares worth about $27 million in the last quarter.
• The company has a market cap of C$2.14 billion, a negative P/E ratio of -12.01, and a high debt-to-equity ratio of -1,831.94.

Bausch Health Companies Inc. (TSE:BHC - Get Free Report)'s stock price dropped 7.2% on Thursday . The stock traded as low as C$7.64 and last traded at C$8.21. Approximately 290,869 shares were traded during mid-day trading, a decline of 18% from the average daily volume of 353,949 shares. The stock had previously closed at C$8.85.

Bausch Health Companies Trading Down 3.4%

The company's fifty day moving average is C$8.17 and its two-hundred day moving average is C$8.53. The stock has a market cap of C$2.05 billion, a price-to-earnings ratio of -11.55, a PEG ratio of 0.21 and a beta of 0.77. The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of -1,831.94.

Insider Buying and Selling

In related news, Director John Paulson purchased 1,782,030 shares of the company's stock in a transaction on Friday, June 13th. The shares were bought at an average cost of C$8.14 per share, for a total transaction of C$14,501,803.73. Insiders have purchased 3,553,401 shares of company stock valued at $27,087,675 in the last 90 days. Corporate insiders own 11.28% of the company's stock.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.